CD8A and hepatocellular carcinoma: In particular, Gabrielson et al. [28] demonstrated that patients with a high density of CD3+ and CD8+ cells in one or both regions of interest (IM or CT) and their corresponding ‘immunoscores’ were associated with a lower rate of HCC recurrence and longer relapse-free survival (RFS).